Author: Tony Scianna, executive vice president, SunGard

It had been a while since I participated in a Twitterview – a real-time interview via Twitter – so I was glad to have the opportunity to join TABB Group’s senior analyst Kevin McPartland in yesterday’s “DerivChat” conversation. SunGard’s own director of analyst relations, Alyssa Gilmore, moderated the discussion, which focused on OTC derivatives.

During the Twitterview, Kevin and I discussed the…